Wuxi, China, Jan. 28, 2026 (GLOBE NEWSWIRE) -- Park Ha Biological Technology Co., Ltd. (NASDAQ: BYAH) (the “Company”) today announced the closing of a best-efforts follow-on public offering of 21,875,000 units (each a “Unit”) at an offering price of US$0.112 per Unit. Each Unit consists of one Class A ordinary share of the Company, par value US$0.00002 per share (each, a “Class A Ordinary Share”) and one warrant to purchase one Class A Ordinary Share, or up to nine Class A Ordinary Shares pursuant to the al ...

Wuxi, China, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Park Ha Biological Technology Co., Ltd. (NASDAQ: BYAH) (the “Company”) today announced the pricing of a best-efforts follow-on public offering of 21,875,000 units (each a “Unit”) at an offering price of US$0.112  per Unit. Each Unit consists of one Class A ordinary share of the Company, par value US$0.00002 per share (each, a “Class A Ordinary Share”) and one warrant to purchase one Class A Ordinary Share (or up to nine Class A Ordinary Shares pursuant to the z ...

Core Points - Park Ha Biological Technology Co., Ltd. will change its ticker symbol from "PHH" to "BYAH" effective October 28, 2025 [1][2] - The change is intended to prevent confusion with a delisted company that previously used the same symbol and aims to enhance the Company's long-term brand influence and value [2] Company Overview - Established in 2016, Park Ha Biological Technology Co., Ltd. focuses on developing its private skincare label and promoting direct skincare product sales and franchise alliances under the brand "Park Ha" [4] - As of April 30, 2025, the Company operates three directly operated stores and has 39 franchisees in China, with 38 operating under "Park Ha" and one under "Geni" [4] - The Company offers a "light beauty experience," a complimentary after-sales beauty service in its stores, to add value to its products [4]